Skip to main content
. 2021 Sep 23;128(12):1917–1921. doi: 10.1007/s00702-021-02420-1

Table 1.

Patients’ characteristics at baseline

Overall n = 29 Responder n = 13 Non-Responder n = 16 P value
Age, years 54 (± 15.6) 58 (± 11.7) 43 (± 19.8) 0.137
Women, n [%] 20 [69] 10 [67] 10 [71] 1.000
Body Mass Index, kg/m2 27 (± 6.5) 30.8 (± 5.4) 25 (± 6.2) 0.558
MADRS 33 (± 8.7) 39 (± 4.4) 34 (± 7.8) 0.314
BDI-II 36 (± 11.3) 46.0 (± 9.7) 38 (± 8.0) 0.199
Duration of current depressive episode, weeks 28 (± 20.1) 19.8 (± 13.0) 29.3 (± 24.7) 0.226
Age at initial diagnosis, years 32 (± 15.6) 30 (± 8.1) 37 (± 23.8) 0.938
History of suicide attempt, n [%] 9 [31] 3 [20] 6 [43] 0.245
Antidepressants, n [%] 17 [59] 10 [67] 7 [50] 0.462
Atypical antipsychotics, n [%] 13 [44.8] 8 [53] 5 [36] 0.462
Norepinephrine, ng/l 35 (± 19.8) 39.3 (± 35.7) 32.8 (± 10.8) 0.678
Epinephrine, ng/l 36 (± 18.8) 45.3 (± 33.1) 28.8 (± 11.4) 0.793
Cortisol, µg/dl 14 (± 6.2) 14.8 (± 1.6) 12.7 (± 5.5) 0.295

Patients’ characteristics presented as mean ± standard deviation (SD) or absolute quantity and percentual (n [%]); MADRS = Montgomery-Åsberg Depression Rating Scale, BDI-II = Beck Depression Inventory-II